Wallingford, United Kingdom

Anne Bridgeman

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anne Bridgeman - Innovator in Viral Particle Preparation

Introduction

Anne Bridgeman is a distinguished inventor based in Wallingford, GB, known for her contributions to the field of immunology. With a focus on developing methods for preparing virus-like particles, she has made significant strides in enhancing immune response mechanisms.

Latest Patents

Bridgeman holds one patent titled "Method for preparing viral particles with cyclic dinucleotide and use of said particles for inducing immune response." This innovative invention relates to techniques for preparing virus-like particles that incorporate immunogenic cyclic dinucleotides, serving as essential components in the development of effective immune responses.

Career Highlights

Throughout her career, Anne Bridgeman has collaborated with esteemed institutions, including the Institut Curie and the Institut National de la Santé et de la Recherche Médicale. Her research endeavors and commitment to scientific progress have positioned her as a key figure in her area of expertise.

Collaborations

In her journey as an inventor, Bridgeman has worked alongside notable peers, including Nicolas Manel and Matteo Gentili. These collaborations have undoubtedly enriched her research and contributed to her innovative output in the field of immunology.

Conclusion

In summary, Anne Bridgeman’s groundbreaking work in preparing viral particles demonstrates the potential of cyclic dinucleotides in medical applications. Her patents and collaborations reflect her dedication to advancing scientific knowledge and improving health outcomes through innovative methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…